Therapeutic applications of chimeric organogenesis

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/36 (2006.01) A61L 27/00 (2006.01) A61L 27/38 (2006.01) A61L 27/60 (2006.01) A61K 35/12 (2006.01) C12N 5/06 (2006.01) C12N 5/08 (2006.01)

Patent

CA 2154368

A process for culturing and generating a chimeric cell culture, in particular chimeric epithelium, is disclosed. The chimeric epithelium oan be used to treat skin trauma such as burn victims. Autologous epithelial grafts have been used on burn patients although this requires that the patient's cells are cultured and expanded in vitro which generally takes four to five weeks. The chimeric epithelium of the present invention is composed of cells that are both autologous and allogeneic to the host. Therefore, the allogeneic cells can be maintained in a cell bank and co--cultured with autologous host cells when needed. This significantly reduces the time required (by up to 50 %) for autologous cell expansion and culture prior to grafting. Furthermore, it has been demonstrated that the allogeneic cells are passively eliminated from the graft without rejection of the total graft.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic applications of chimeric organogenesis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic applications of chimeric organogenesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic applications of chimeric organogenesis will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1596229

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.